Does Childhood Physical Neglect Predict Methamphetamine-Positive Urine Tests? Evidence From 115 Outpatients

Answer first: In an observational Taiwanese study of 115 adults with methamphetamine use disorder, participants reporting childhood physical neglect had poorer baseline performance on selected Wisconsin Card Sorting Test measures and greater self-reported craving. In adjusted analyses of repeated treatment observations, reported physical neglect was associated with a greater likelihood of a methamphetamine/amphetamine-positive urine-screen classification (reported model coefficient B = 2.14, 95% CI 0.41–3.87; p = .02). Other childhood-trauma categories did not show significant adjusted associations with urine positivity in that table. These are group associations, not a validated personal relapse forecast, proof of drug exposure at a particular hour, or a measure of legally collected venous whole-blood methamphetamine.

The actual primary investigation by Lin and colleagues appeared in Clinical Psychopharmacology and Neuroscience in 2025. Read the original empirical study and its complete numerical tables (DOI 10.9758/cpn.24.1248) for the clinical recruitment, statistical adjustment, repeat-assessment design and authors’ limitations. The source also has important missing-data details: 115 people entered, 64 finished the year, and its year-end table displays only 51 urine-result classifications. Those numbers must not be collapsed into one interchangeable denominator.

What precise question can this observational study answer?

The defensible question is whether retrospectively reported categories of adverse childhood experience, especially physical neglect, co-occurred with baseline cognitive-task scores and with specified treatment-monitoring outcomes during one year of outpatient care. The investigators used standardized questionnaires, card-sorting performance, craving and dependence ratings, and repeated categorical urine-screen results. They did not allocate childhood experiences experimentally, randomize methamphetamine exposure or compare a drug with placebo.

The observed patterns are useful for formulating hypotheses about treatment engagement and possible clinical support needs. They cannot determine whether trauma caused a particular person’s methamphetamine use, whether a person was chemically positive without a collected specimen, or why an individual driver or witness behaved a certain way. An association derived from a cohort model is evidence about groups under the study’s sampling and adjustment assumptions.

Who were the 115 independently enrolled participants?

The study recruited 115 adults diagnosed with methamphetamine use disorder in an outpatient program in Taiwan. At enrollment, 106 were men and nine were women, and mean age was 35.8 years. Participants reported histories of methamphetamine use; some had psychiatric comorbidities or other substance-use histories. All were patients selected into treatment rather than a randomly sampled general population or an experimental acute-dose cohort.

Each participant is one independent biological person, irrespective of how many childhood-questionnaire items, treatment visits, urine samples or Wisconsin Card Sorting Test responses that person contributed. Those nested observations are not hundreds of new independent patients. There is no comparison arm of otherwise matched people randomized to have or not have childhood neglect, and no contemporaneous controlled methamphetamine administration.

Why must baseline 115, year-end 64 and tested-urine 51 remain separate?

The original account states that 64 of 115 participants completed the full year of treatment—substantial attrition. Table 1 labels its later column “After 1 year of treatment (n = 64)” but lists four positive and 47 negative urine results, totaling 51 actual classifications. The printed 7.8% later positive proportion corresponds to four of those 51, not four of 64 or four of the original 115. The research does not justify silently treating the remaining participants as negative or positive without a reported collected specimen.

At baseline, the table lists 29 positive and 86 negative classifications, summing to all 115. Those two snapshots are not a complete individually paired biochemical exposure history, and baseline-to-year-end changes cannot be called a controlled treatment effect. Attrition may selectively remove patients with more complex conditions, including psychiatric and social difficulties, changing who remains available for measurement.

How did the treatment program and repeated measurements operate?

Participants entered a three-stage outpatient plan. The first four weeks generally involved weekly visits and urine screening. Over the next eight weeks visits and screens were scheduled approximately every two weeks, with supportive psychotherapy, education, service linkage and group cognitive-behavioral therapy. The remaining 36 weeks involved monthly follow-ups and continued counseling, motivational support and screening. This was a package of real-world outpatient care, not a randomized trial isolating one single treatment ingredient.

Questionnaires measuring craving and dependence were administered during the course of treatment; the Wisconsin Card Sorting Test was used at enrollment and later follow-up. Urine screening could classify an actual submitted specimen at each visit. Repeated visits are correlated observations within a patient; the generalized estimating equation analysis sought to account for such within-person structure. It does not turn missing specimens into chemical assay data or remove all selection bias.

What exactly did “physical neglect” mean in this paper?

Adverse experience was recorded with the Childhood Trauma Questionnaire–Short Form, a retrospective 28-item self-report instrument. It separates emotional abuse, physical abuse, sexual abuse, emotional neglect and physical neglect. Under the paper’s adopted cutoffs, a physical-neglect subscale score of at least eight placed a person in the physical-neglect-positive subgroup. That is a questionnaire-based classification of reported earlier experience—not independent forensic verification of every childhood episode.

Eighty-eight of the 115 met the study’s physical-neglect criterion; the remaining 27 did not. The same count of 88 was also reported for emotional neglect, but identical totals do not prove that the 88 participants in those categories were exactly the same people. Trauma dimensions may overlap. The study’s subgroup contrasts cannot be read as five disjoint groups of new individuals.

What does the Wisconsin Card Sorting Test measure—and not measure?

The Wisconsin Card Sorting Test requires a participant to infer shifting classification rules from feedback and then alter their responses when the rule changes. The original paper reported total errors (TNE), perseverative errors, categories completed (NCC) and conceptual-level responding (CL). These variables reflect aspects of task-based executive control, mental flexibility and response updating under specified testing conditions. They are not laboratory measurements of methamphetamine, dopamine or childhood adversity.

Interpretation depends on the particular scoring definition. More total errors are generally less favorable, whereas more correctly completed categories typically represent better task performance. A WCST score is not a validated legal intoxication threshold or a diagnostic test for the cause of an individual brain injury. Performance can be influenced by sleep, education, psychiatric illness, instructions, motivation, language, practice and other factors that may overlap with trauma history and substance use.

What were the original baseline physical-neglect subgroup differences?

At baseline, the physical-neglect-positive subgroup had more WCST total errors, completed fewer WCST categories and showed a lower conceptual-level score than participants below the physical-neglect threshold. The authors reported these three differences as statistically significant with p values .02, .03 and .02, respectively. Self-reported craving also differed according to the original Table 2 significance marker. The differences arise from two unequal, nonrandom subgroups: 88 versus 27 people.

The following evidence table is independently reorganized from original Table 2. It intentionally separates the values from their implications rather than constructing a hypothetical clinical cutoff or reproducing publisher table artwork. The mere numerical difference in perseverative-error scores was not marked significant by the original source. A post hoc argument that every test component was significant would misstate its own findings.

How strong was the adjusted association with urine-test classification?

The central adjusted result appeared in the paper’s Table 3, which used generalized estimating equations for repeated outpatient observations. The row for physical neglect reported B = 2.14, 95% CI 0.41–3.87, Wald χ² = 5.90 and p = .02 for a positive urine methamphetamine/amphetamine classification. Because the underlying model’s outcome link and coefficient scale must be honored, the published B should not be casually redescribed as an odds ratio, a 214% increase, a drug concentration or a validated individual risk probability.

The adjustment included specified demographic, psychiatric, substance-severity, craving, baseline dependence and visit-related covariates. Such adjustment can reduce confounding only for variables accurately measured and included; it cannot make observational childhood experiences random. A positive model coefficient answers the source’s group-association question under a specified model. It does not identify which future sample from a particular person must test positive.

Which other childhood-trauma comparisons were genuinely nonsignificant?

Four other original Table 3 categories did not meet the reported .05 threshold for adjusted urine positivity: emotional abuse (p = .57), sexual abuse (p = .14), physical abuse (p = .91) and emotional neglect (p = .59). The coefficients and confidence intervals for these categories appear in the second evidence table. It would be false to say every category of childhood trauma independently predicted a positive urine screen, or that the pattern proves childhood neglect uniquely causes renewed drug use.

Conversely, a nonsignificant comparison is not evidence that two childhood-experience groups are biologically identical or that the exposure can never matter. These were overlapping self-reported categories within one clinical cohort, with unequal subgroup sizes and uncertain power. The correct formulation is that the specified adjusted tests did not establish those four associations in these data.

Was sexual abuse associated with a different treatment measurement?

Yes. The reported sexual-abuse subgroup was associated with a higher Severity of Dependence Scale score over the repeated treatment assessments, with the authors reporting p = .004. That outcome concerns a self-reported psychological dependence measure, not urine-positive frequency. The source therefore identifies different statistical patterns for different exposure categories and different measurement endpoints.

Collapsing sexual abuse, physical neglect, craving, urine tests and dependence into a single generic “trauma predicts relapse” statement erases those critical distinctions. The paper did not establish that a historical category causes a measured positive specimen in a particular person. It also did not demonstrate a clinical intervention targeted to one trauma category that changes actual biochemical outcomes compared with a randomized control.

What did repeated craving and WCST analyses indicate?

The authors described persistently higher craving in participants classified as physical-neglect-positive, reporting an adjusted repeated-measures association with craving VAS scores (p = .002). They also identified associations between physical neglect and fewer WCST categories completed (p = .02) and lower conceptual-level responses (p = .046, described in the source as passing its false-discovery-rate approach). Those longitudinal findings concern psychological ratings and standardized card-sorting outcomes, each of which has its own measurement scale.

A craving rating is an introspective response to a question about a preceding week; a WCST response is a behavior during a structured task; a urine screen is a biological specimen classification. They are not interchangeable proxies for a calibrated methamphetamine blood concentration. The source’s adjustment and multiplicity treatment should be checked before describing a marginal corrected p = .046 as decisive proof of a mechanism.

Why do urine, serum, plasma and whole blood matter separately?

The paper described urine MA/amphetamine testing during care, not a quantitative forensic venous whole-blood assay. Urine is an excretory matrix. A positive classification depends on a specimen having been collected, its integrity, target analytes, the laboratory’s screening threshold, possible cross-reactivity and whether confirmatory chromatography was performed. The original report does not give enough assay-specific validation to reconstruct a person’s quantitative exposure from its binary table.

Serum and plasma are liquid fractions separated from blood cells, whereas venous whole blood retains those cells. Their analyte concentrations and units cannot be assumed equivalent to a urine positive/negative flag. This primary study did not provide legally collected human venous whole-blood methamphetamine concentrations, a specific confirmatory LC–MS/MS or GC–MS quantitative time series, validated blood-to-urine conversion, or individualized elimination kinetics. For a technical overview see biological matrices in toxicology.

Can a presumptive urine result identify parent methamphetamine?

Not necessarily. Depending on the laboratory method, a category labeled “MA/amphetamine positive” may arise from a presumptive class-based screening result or a more selective confirmatory technique. The study did not publish specimen-by-specimen confirmatory chromatograms, d- versus l-isomer separation, concentrations, analytical uncertainty, calibration curves or legal chain-of-custody documentation needed to treat these categories as resolved forensic identifications.

A confirmed specimen-specific result can support a particular analytical proposition when validation and collection records permit it. But an unqualified category in a clinical outcomes study does not itself distinguish methamphetamine from every cross-reactant, establish what was in plasma or whole blood, determine recent route and dose, or prove psychomotor impairment. The related confirmatory drug testing guide explains the importance of method selectivity and matrix-specific validation.

Do the reported improvements from baseline prove treatment efficacy?

No. Many patients received a mixture of supportive interventions across the year, while attrition was pronounced. A lower percentage of positive classifications among specimens represented in the later Table 1 column may reflect treatment effects, selective follow-up, time-related changes, external drug availability, changes in motivation and the composition of patients providing samples. The study did not randomly assign a trauma intervention against a placebo or another controlled treatment that could isolate causation.

The apparently lower year-end positive percentage uses 51 actual reported urine classifications rather than all 115 baseline participants. Without a complete missingness model and separately reconciled participant-level outcomes, an expert should not turn the descriptive comparison into a 17.4-percentage-point causal reduction in drug use for the entire cohort. A categorical classification also supplies no information about how much methamphetamine was present at a given time.

What does loss to follow-up do to these associations?

Forty-four percent of enrolled participants did not complete the entire course. The source reports that those who left treatment disproportionately had factors such as polysubstance use, psychiatric comorbidity, unemployment, hepatitis C serology, histories of some trauma categories and fewer years of schooling. Those are precisely the sorts of variables that can be related to both continued participation and the outcomes under analysis. Attrition is therefore potentially informative, not safely ignorable.

A generalized estimating equation can accommodate correlated repeated records under assumptions, but cannot by itself manufacture biochemical results for missing visits or prove that dropout is independent of unobserved outcomes. It is important to distinguish the 64 individuals classified as program completers from the 51 later urine tests actually listed. The source does not present an external validation exercise establishing a calibrated personal forecast despite this incomplete follow-up.

Can the study establish that childhood adversity caused substance use?

No. The trauma variables were retrospective self-reports among people already diagnosed with methamphetamine use disorder; no prospective childhood exposure assignment or independent contemporaneous verification was part of the experiment. Childhood adversity may co-occur with socioeconomic hardship, later psychiatric symptoms, different access to care, sleep disruption and other experiences not fully captured by adjustment. Some variables may be mediators, confounders or both.

The authors themselves did not establish causal direction. Their finding is important as a hypothesis about clinical histories associated with cognitive and treatment-related measurements, but causation would require an explicitly designed comparison and stronger temporal and confounding control. It cannot substantiate an inference that a particular person’s history chemically caused a later positive specimen or a particular act in litigation.

What source-reporting discrepancies should an expert notice?

The original article describes 64 program completers in its Results and later-column heading, yet only 51 later urine classifications are displayed. Elsewhere its Discussion refers to a small sample of “62 patients,” which conflicts with the explicit 64-completer description. The percentages in some psychiatric-comorbidity rows also do not always reconcile to the displayed group denominator. These discrepancies should not be silently repaired or interpreted as proof of misconduct.

Instead, the analyst should show the reported quantities exactly, use the defensible denominator where apparent, and identify unresolved source arithmetic separately before any individualized opinion. The original participant-level data or an author clarification would be needed to decide whether the missing urine records were collected but unreported, excluded from that summary or unavailable for other reasons. No additional specimen or p value should be invented to close the gap.

Can these numbers predict one person’s relapse or driving impairment?

They cannot do so in a validated individual forensic sense. The paper reports subgroup comparisons and repeated-outcome associations; it does not publish a prespecified point-scoring algorithm, validated sensitivity and specificity, prediction calibration, external replication cohort or individual decision threshold. Nor does it measure whether a specific person resumed use on a given day rather than remaining intermittently screened positive at clinical visits.

Driving impairment, eyewitness accuracy, intoxication at an incident and legal culpability were not tested endpoints. A patient’s childhood report, WCST error count, VAS-C craving score and urine-screen category cannot be converted mathematically into a whole-blood concentration or a reason for a particular crash. A reliable case opinion requires event-specific contemporaneous behavior and appropriately identified analytical specimens, methods and uncertainty.

How is this different from prior cognitive-testing research?

This study isolates a particular historical-exposure subgroup question: childhood physical neglect versus other childhood-trauma categories, coupled to baseline WCST and repeated year-long categorical urine outcomes. That is distinct from an earlier 98-patient six-month outpatient WCST study in which missing scheduled specimens were explicitly coded positive, and from a separate 30-patient contingency-management analysis centered on CPT and Trail Making B. The designs, original participants, outcome rules and primary research questions differ.

These separate investigations should not be presented as independent replication of an identical effect size or stitched together into a stronger individual drug prediction than any actually validated. Different cohorts cannot justify manufacturing a pooled diagnostic cutoff. The value of the present primary data is its careful distinction of exposure type, measured executive functions, selected significant associations, observed null comparisons and material follow-up limitations.

What is the bounded forensic-science takeaway?

The strongest source-faithful answer is that physical-neglect questionnaire status was associated with differences in selected WCST performance measures and with a positive urine MA/amphetamine screening category over repeated outpatient assessments, while most other trauma-category comparisons for urine positivity were nonsignificant. Sexual-abuse status was separately associated with a dependence-severity measure. Those observations belong to a selected cohort of 115 people with only 64 program completers and 51 later urine records tabulated.

A sound forensic report can describe the model estimates, actual denominators, significant and null tests, and methodological uncertainty. It cannot claim that any childhood category proves an exact drug dose, a chemically confirmed human whole-blood concentration, personal relapse, impaired driving, witness dishonesty or the cause of an incident. The study is scientifically relevant when its measured question stays separate from those unmeasured legal propositions.

Frequently asked scientific and forensic questions

1. Does physical neglect prove a person used methamphetamine during a particular day?

No. Retrospective questionnaire status was associated with a group-level repeated positive urine-screen outcome. The authors neither continuously observed each participant nor established the timing of every ingestion. No sample-independent personal last-use rule was validated.

2. How many different people were actually tested?

There were 115 independent enrollees, 88 meeting the physical-neglect definition and 27 not meeting it. Sixty-four were listed as completing the year, while the year-end tabulated urine results numbered 51. Follow-up visits and questionnaire responses are repeated observations, not additional people.

3. Was every childhood trauma category significantly associated with a positive urine result?

No. Adjusted Table 3 comparisons for emotional abuse, sexual abuse, physical abuse and emotional neglect had p values .57, .14, .91 and .59. Physical neglect was the sole category with a statistically significant reported positive urine-screen association in that table (p = .02).

4. Did the investigators measure whole-blood methamphetamine concentrations?

No. The source reported categorical clinical urine MA/amphetamine tests, not chemically calibrated parent methamphetamine in legally collected human venous whole blood. It did not provide quantitative blood drug mass spectrometry, isomer identification or an individual toxicokinetic elimination curve.

5. Can the reported GEE B of 2.14 be used as a 2.14-fold odds ratio?

Not without confirming the original model link and coefficient scale. The paper labels it B and gives a confidence interval. It is safer to reproduce the reported coefficient and p value as an adjusted association, rather than silently interpreting it as an odds ratio, blood concentration or probability.

6. What does the difference between 64 completers and 51 year-end urine records mean?

It means the study reports at least two distinct quantities. Its year-end column identifies 64 treatment completers while displaying only four positive and 47 negative urine classifications, so the printed 7.8% refers to 4/51. It cannot verify the test status of unreported specimens.

7. Can WCST scores or childhood-trauma history establish impaired driving or witness unreliability?

No. Neither driving nor eyewitness credibility was measured. Group differences in card-sorting behavior and urine-screen categories do not provide a validated individual impairment threshold, establish the cause of a crash or assess truthfulness at an incident.

Primary empirical study: Lin C-T, Wang T-Y, Tsai T-Y, Tseng H-H, Chen K-C, Lee I H, Chen P S, Yang Y K, Lu R-B (2025). The Association between Childhood Trauma on Executive Functioning and Treatment Outcomes among Individuals with Methamphetamine Use Disorder. Clinical Psychopharmacology and Neuroscience 23(2):300–311. Consult the source article, original tables and underlying reporting limitations. This independent research explanation does not replace participant-level clinical records, specimen-specific laboratory documentation or an individualized expert assessment.